Brief: Stayble Therapeutics Q4 EBIT Loss At SEK 4.6 Mln
21/02/2023 07:13
Feb 21 (Reuters) - Stayble Therapeutics AB STABL.ST :
* Q4 EBIT LOSS SEK 4.6 MILLION VERSUS LOSS SEK 4.6 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkr89V965
Further company coverage: STABL.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln